Aelis Farma SA(FR:AELIS)
€0.88+0.01 (+1.63%)
FR:AELIS
Aelis Farma SA technical analysis
€0.88
At close:+0.01 (+1.63%)
Want to see FR:AELIS full AI Analyst Report?
Aelis Farma SA (AELIS) Technical Analysis
3 Followers
Technical Sentiment
Overall ConsensusStrong Sell Strong Buy Buy
7Bearish
5Neutral
10Bullish
Technical Analysis ConsensusStrong Sell Strong Buy Neutral
2Bearish
5Neutral
3Bullish
Moving Average ConsensusStrong Sell Strong Buy Buy
5Bearish
0Neutral
7Bullish
1 Day timeframe · Data as of Nov 11, 2026
- Aelis Farma SA’s (AELIS) Moving Averages Convergence Divergence (MACD) indicator is 0.01, suggesting Aelis Farma SA is a Sell.
- Aelis Farma SA’s (AELIS) 20-Day exponential moving average is 0.80, while Aelis Farma SA’s (AELIS) share price is €0.88, making it a Buy.
- Aelis Farma SA’s (AELIS) 50-Day exponential moving average is 0.84, while Aelis Farma SA’s (AELIS) share price is €0.88, making it a Buy.
Aelis Farma SA (AELIS) Pivot Points
1 Day timeframe · Data as of Nov 11, 2026
| Name | S3 | S2 | S1 | Pivot Points | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Classic | 0.72 | 0.79 | 0.82 | 0.89 | 0.92 | 0.99 | 1.02 |
| Fibonacci | 0.79 | 0.82 | 0.85 | 0.89 | 0.92 | 0.95 | 0.99 |
Aelis Farma SA (AELIS) Moving Averages
1 Day timeframe · Data as of Nov 11, 2026
| Period | Simple | Exponential |
|---|---|---|
| MA5 | 0.89Sell | 0.87Buy |
| MA10 | 0.81Buy | 0.83Buy |
| MA20 | 0.76Buy | 0.80Buy |
| MA50 | 0.84Buy | 0.84Buy |
| MA100 | 0.94Sell | 0.93Sell |
| MA200 | 1.11Sell | 1.05Sell |
- Aelis Farma SA’s (AELIS) 10-Day exponential moving average is 0.83, while Aelis Farma SA’s (AELIS) share price is €0.88, making it a Buy.
- Aelis Farma SA’s (AELIS) 100-Day exponential moving average is 0.93, while Aelis Farma SA’s (AELIS) share price is €0.88, making it a Sell.
- Aelis Farma SA’s (AELIS) stock price is €0.88 and Aelis Farma SA’s (AELIS) 50-day simple moving average is 0.84, creating a Buy signal.
- Aelis Farma SA’s (AELIS) stock price is €0.88 and Aelis Farma SA’s (AELIS) 100-day simple moving average is 0.94, creating a Sell signal.
- Aelis Farma SA’s (AELIS) stock price is €0.88 and Aelis Farma SA’s (AELIS) 200-day simple moving average is 1.11, creating a Sell signal.
Aelis Farma SA (AELIS) Technical Indicators
1 Day timeframe · Data as of Nov 11, 2026
| Name | Value | Implied Action |
|---|---|---|
| RSI (14) | 57.40 | Neutral |
| STOCH (9,6) | 46.58 | Neutral |
| STOCHRSI (14) | 53.66 | Neutral |
| MACD (12,26) | 0.01 | Sell |
| ADX (14) | 37.18 | Neutral |
| Williams %R | -48.86 | Buy |
| CCI (14) | 116.55 | Sell |
| ATR (14) | 0.06 | - |
| Ultimate Oscillator | 52.41 | Neutral |
| ROC | 22.22 | Buy |
- Aelis Farma SA’s (AELIS) Relative Strength Index (RSI) is 57.40, creating a Neutral signal.
- Aelis Farma SA’s (AELIS) Trend Strength Indicator (ADX) is 37.18, creating a Neutral signal.
- Aelis Farma SA’s (AELIS) Commodity Channel Index (CCI) is 116.55, creating a Sell signal.
- Aelis Farma SA’s (AELIS) Price Rate of Change (ROC) is 22.22, creating a Buy signal.
unique trading strategy with a flexible screenerTry it Now!
FAQ
Is AELIS a Buy, Hold, or Sell?
Based on AELIS’s technical indicators on the 1-day timeframe as of Nov 11, 2026, AELIS is a Buy.
What is AELIS’s RSI (14)?
AELIS’s RSI (14) is 57.40, which suggests AELIS is a Neutral.
What is AELIS’s MACD?
AELIS’s MACD is 0.01, which suggests AELIS is a Sell.
What is AELIS’s 5-day moving average?
AELIS’s 5-day moving average is 0.89, which suggests AELIS is a Sell.
What is AELIS’s 20-day moving average?
AELIS 20-day moving average is 0.76, which suggests AELIS is a Buy.
What is AELIS’s 50-day moving average?
AELIS’s 50-day moving average is 0.84, which suggests AELIS is a Buy.
What is AELIS’s 200-day moving average?
AELIS’s 200-day moving average is 1.11, which suggests AELIS is a Sell.
What is AELIS’s Williams % R (14)?
AELIS’s Williams % R (14) is -48.86, which suggests AELIS is a Buy.
What is AELIS’s CCI (14)?
AELIS’s CCI (14) is 116.55, which suggests AELIS is a Sell.
What is the share price of Aelis Farma SA?
Aelis Farma SA's share price is N/A€.

